Leadership Overview
Omnicell has 6 executives leading key functions including strategy, operations, marketing, technology, finance, and human resources.
Focused on transforming the pharmacy care delivery model, Omnicell advances medication management through innovative automation and analytics to improve patient safety and operational efficiency across global healthcare systems.
Focused on transforming the pharmacy care delivery model, Omnicell advances medication management through innovative automation and analytics to improve patient safety and operational efficiency across global healthcare systems.
Leadership Roles at Omnicell
Randall Lipps - Chairman, Chief Executive Officer & Founder
Randall Lipps, the Chairman, Chief Executive Officer & Founder at Omnicell, directs the overarching strategic vision for the organization. By prioritizing the development of medication management solutions, Lipps guides the company toward long-term growth within the global healthcare technology sector. This leadership role involves constant engagement with the Board to ensure alignment between corporate objectives and market demands. Randall Lipps maintains a focus on expanding the reach of automated dispensing systems across international markets, including North America and Europe. Through the integration of advanced analytics and robotic pharmacy automation, the Chief Executive Officer drives improvements in patient safety and clinical outcomes. By fostering a culture of innovation, Lipps ensures the company remains at the forefront of pharmacy technology, consistently delivering value to healthcare providers and patients alike while maintaining a competitive edge in the rapidly evolving medical manufacturing landscape.
Baird Radford - Executive Vice President & Chief Financial Officer
Baird Radford, the Executive Vice President & Chief Financial Officer at Omnicell, manages the financial health and capital allocation strategies of the organization. By overseeing financial planning, reporting, and investor relations, Radford ensures the company maintains the resources necessary to support global expansion and product development. This role involves analyzing market performance across the United States and international regions to guide strategic investment decisions. Baird Radford drives fiscal discipline by optimizing cost structures and monitoring revenue growth from medication management and analytics software. Through collaboration with the executive team, the Executive Vice President & Chief Financial Officer provides the financial insights required to evaluate potential acquisitions and long-term growth opportunities. By maintaining transparency with shareholders and the financial community, Radford supports the overall stability and market valuation of the company. This leadership position focuses on balancing immediate financial performance with the long-term goals of the healthcare technology business.
Nnamdi Njoku - President & Chief Operating Officer
Nnamdi Njoku, the President & Chief Operating Officer at Omnicell, manages the daily execution of global business operations. Overseeing the manufacturing and distribution of medication management technologies, Njoku ensures that supply chain logistics meet the high standards required by healthcare systems worldwide. This role requires close collaboration with regional leaders to optimize performance across the United States, Canada, and Australia. Nnamdi Njoku drives operational efficiency by streamlining internal processes and enhancing the delivery of automated dispensing systems. By monitoring key performance indicators, the President & Chief Operating Officer identifies opportunities for scaling production and improving service reliability. Through rigorous oversight of operational workflows, Njoku supports the company mission to reduce medication errors. This leadership position demands a focus on maintaining high-quality standards while navigating the complexities of international regulatory environments, ultimately ensuring that healthcare providers receive the necessary tools to improve patient care.
Stella Prefach - Senior Vice President and Chief Marketing Officer
Stella Prefach, the Senior Vice President and Chief Marketing Officer at Omnicell, architects the global brand strategy and market positioning for all medication management solutions. By analyzing industry trends and customer needs, Prefach develops targeted campaigns that highlight the value of robotic pharmacy automation and EnlivenHealth patient engagement tools. This role involves coordinating with sales teams to penetrate new markets across the United Kingdom, France, and Germany. Stella Prefach drives demand generation by articulating the clinical and financial benefits of the company product portfolio to hospital administrators and retail pharmacy leaders. Through the management of marketing communications and product launches, the Senior Vice President and Chief Marketing Officer ensures consistent messaging that resonates with healthcare providers. By leveraging data-driven insights, Prefach optimizes the customer journey, ultimately increasing market share and strengthening the reputation of the company as a leader in healthcare technology innovation.
Perry Genova - Senior Vice President and Chief Technology Officer
Perry Genova, the Senior Vice President and Chief Technology Officer at Omnicell, leads the research and development of next-generation pharmacy automation and analytics software. By overseeing the engineering teams, Genova drives the creation of scalable technology platforms that support inpatient and outpatient pharmacy settings. This role involves integrating advanced software capabilities into existing hardware to enhance medication adherence and supply management. Perry Genova collaborates with product managers to ensure that technical roadmaps align with the evolving needs of global healthcare systems. Through the implementation of robust cybersecurity measures and data analytics, the Senior Vice President and Chief Technology Officer protects critical patient information while improving operational workflows. By fostering a culture of technical excellence, Genova ensures the company maintains a competitive advantage in the medical manufacturing industry. This leadership function focuses on continuous innovation, ensuring that all technological solutions meet the highest standards of safety and efficiency.
Max Rocha - Senior Vice President & Chief People Officer
Max Rocha, the Senior Vice President & Chief People Officer at Omnicell, directs the human capital strategy and organizational development initiatives. By overseeing talent acquisition, employee engagement, and leadership development, Rocha ensures the company attracts and retains the expertise required to drive innovation in healthcare technology. This role involves fostering an inclusive culture that supports the diverse workforce operating across multiple countries. Max Rocha implements performance management systems that align individual contributions with the broader mission of improving patient safety and operational efficiency. Through the design of competitive compensation and benefits programs, the Senior Vice President & Chief People Officer supports the well-being and professional growth of the entire staff. By collaborating with other C-suite leaders, Rocha ensures that organizational structure and talent deployment remain agile in response to market changes. This leadership function focuses on building a high-performing team capable of executing the complex goals of the company.
Explore Leadership Teams in Manufacturing
Founded in 1989 and headquartered in Princeton, New Jersey, Integra LifeSciences is a medical technology company that develops and manufactures surgical instruments, neurosurgical devices, and advanced wound care and tissue repair products. Through its Codman Specialty Surgical and Tissue Technologies segments, the company serves neurosurgeons, neurocritical care teams, ENT specialists, plastic and reconstructive surgeons, and general surgeons. Its portfolio includes neurosurgical tools and systems such as dural repair products, cerebrospinal fluid management devices, intracranial monitoring equipment, and cranial stabilization devices, as well as surgical headlamps and general surgical instruments. Integra also provides specialized solutions for acute and chronic wound management, including burns and diabetic foot ulcers, and offers products for soft tissue, bone, nerve, and tendon repair. In ear, nose, and throat care, the company supplies instrumentation, balloon technologies for sinus and eustachian tube dilation, and surgical navigation systems. Sold through direct sales teams and distribution partners to hospitals, surgery centers, and healthcare providers worldwide, Integra LifeSciences positions itself as a comprehensive partner for complex surgical and reconstructive care.
Company Leadership SE
CV
Headquartered in North Carolina, Medical Manufacturing Technologies (MMT) offers manufacturing-as-a-service that brings together applications expertise, technical solutions, and aftermarket support to revolutionize medical device manufacturing.
Company Leadership VS
TS
RS
AC
Enovis is a global medical technology innovator focused on improving lives by creating clinically differentiated solutions that help restore motion and enhance patient outcomes. The company partners with leading experts in healthcare to advance smarter, personalized, and more effective care while supporting the operational needs of surgeons and clinicians. Driven by a culture of continuous improvement, innovation, and strategic growth, Enovis offers a broad portfolio of products, services, and integrated technologies, including well-known brands that support patients throughout their journey to better health.
Company Leadership LV
JM
OE
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Company Leadership
KU
Frequently Asked Questions Regarding Omnicell Top Executives and Leadership Team
Unlock more people and company data
